BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16917006)

  • 1. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.
    Biggar RJ; Jaffe ES; Goedert JJ; Chaturvedi A; Pfeiffer R; Engels EA
    Blood; 2006 Dec; 108(12):3786-91. PubMed ID: 16917006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
    Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
    J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma.
    Kowalkowski MA; Mims MP; Amiran ES; Lulla P; Chiao EY
    PLoS One; 2013; 8(10):e77409. PubMed ID: 24098586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
    Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes.
    Bohlius J; Schmidlin K; Boué F; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Paparizos V; Miro JM; Obel N; Prins M; Chêne G; Egger M;
    Blood; 2011 Jun; 117(23):6100-8. PubMed ID: 21368291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
    Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
    HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.
    Engels EA; Pfeiffer RM; Landgren O; Moore RD
    J Acquir Immune Defic Syndr; 2010 May; 54(1):78-84. PubMed ID: 20418723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan.
    Yotsumoto M; Hagiwara S; Ajisawa A; Tanuma J; Uehira T; Nagai H; Fujikawa Y; Maeda S; Kitano K; Arima N; Uno K; Iwai T; Hongo I; Ota Y; Fukutake K; Okada S
    Int J Hematol; 2012 Aug; 96(2):247-53. PubMed ID: 22752537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
    Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E;
    AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.
    Xicoy B; Ribera JM; Miralles P; Berenguer J; Rubio R; Mahillo B; Valencia ME; Abella E; López-Guillermo A; Sureda A; Morgades M; Navarro JT; Esteban H; ;
    Haematologica; 2007 Feb; 92(2):191-8. PubMed ID: 17296568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated Hodgkin lymphoma.
    Carbone A; Gloghini A; Serraino D; Spina M
    Curr Opin HIV AIDS; 2009 Jan; 4(1):3-10. PubMed ID: 19339934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
    Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
    J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART.
    Lapadula G; Chatenoud L; Gori A; Castelli F; Di Giambenedetto S; Fabbiani M; Maggiolo F; Focà E; Ladisa N; Sighinolfi L; Di Pietro M; Pan A; Torti C;
    PLoS One; 2015; 10(5):e0124741. PubMed ID: 26020949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing HIV and Hodgkin lymphoma in the twenty-first century.
    Aries J; Montoto S
    Curr Hematol Malig Rep; 2014 Sep; 9(3):227-32. PubMed ID: 24906351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
    Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
    Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
    Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors.
    Re A; Michieli M; Casari S; Allione B; Cattaneo C; Rupolo M; Spina M; Manuele R; Vaccher E; Mazzucato M; Abbruzzese L; Ferremi P; Carosi G; Tirelli U; Rossi G
    Blood; 2009 Aug; 114(7):1306-13. PubMed ID: 19451551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.